- Email: [email protected]
AS-192: Angiographic and Clinical Outcomes following Hybrid Stenting with Drug-Eluting Stents in Chronic Total Occlusion Intervention
April 24 –27, 2012 However, this mid-term angiographic difference did not exert on worse clinical outcomes at least up to twelve months (Table). Conclusion: In pts undergoing CTO intervention with DESs, the occlusion duration had no major impact on procedural outcomes, midterm angiographic and one-year clinical outcomes.
AS-192 Angiographic and Clinical Outcomes following Hybrid Stenting with Drug-Eluting Stents in Chronic Total Occlusion Intervention. Seung-Woon Rha, Amro Elnagar, Se Yeon Choi, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Hong Seog Seo, Chang Gyu Park, Dong Joo Oh. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea (Republic of).
hybrid stenting group (45.47⫾27.02 vs. 38.87⫾25.57, p⫽0.035). At six months angiographic follow up, late loss was higher in the hybrid stenting group. The incidence of target vessel revascularization (TVR), TVR-major adverse cardiac event (MACE) and all MACE were higher in the hybrid stenting group at 12 months (Table). Conclusion: In the current study, hybrid DES stenting for long CTO lesion showed higher late loss at 6 months and subsequent increased repeat PCI and MACE at 12 months. However, this need further randomized study with larger study population to get final conclusion. Table. Six months angiographic and 12 months clinical outcomes
Background: The implantation of multiple overlapping stenting in patients (pts) with a diffuse long coronary lesion is relatively safe and effective in drug eluting stents (DES) era. However, the safety and efficacy of overlapping stenting with a different type of DES in chronic total occlusion (CTO) intervention remain unknown. Methods: A total 267 consecutive pts who underwent percutaneous coronary intervention (PCI) with DESs for CTO lesions were enrolled for this study. We compared the angiographic and clinical outcomes of Same DES strategy (n⫽228) to hybrid DES strategy (n⫽39). Results: Baseline clinical characteristics were similar between the two groups. At index procedure, angiographic and procedural parameters were also similar except for CTO length which was longer in
P O S T E R A B S T R A C T S
The American Journal of Cardiology姞 APRIL 24 –27, 2012 ANGIOPLASTY SUMMIT ABSTRACTS/Poster
97S
AS-192 Angiographic and Clinical Outcomes following Hybrid Stenting with Drug-Eluting Stents in Chronic Total Occlusion Intervention. Seung-Woon Rha, Amro Elnagar, Se Yeon Choi, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Hong Seog Seo, Chang Gyu Park, Dong Joo Oh. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea (Republic of).
hybrid stenting group (45.47⫾27.02 vs. 38.87⫾25.57, p⫽0.035). At six months angiographic follow up, late loss was higher in the hybrid stenting group. The incidence of target vessel revascularization (TVR), TVR-major adverse cardiac event (MACE) and all MACE were higher in the hybrid stenting group at 12 months (Table). Conclusion: In the current study, hybrid DES stenting for long CTO lesion showed higher late loss at 6 months and subsequent increased repeat PCI and MACE at 12 months. However, this need further randomized study with larger study population to get final conclusion. Table. Six months angiographic and 12 months clinical outcomes
Background: The implantation of multiple overlapping stenting in patients (pts) with a diffuse long coronary lesion is relatively safe and effective in drug eluting stents (DES) era. However, the safety and efficacy of overlapping stenting with a different type of DES in chronic total occlusion (CTO) intervention remain unknown. Methods: A total 267 consecutive pts who underwent percutaneous coronary intervention (PCI) with DESs for CTO lesions were enrolled for this study. We compared the angiographic and clinical outcomes of Same DES strategy (n⫽228) to hybrid DES strategy (n⫽39). Results: Baseline clinical characteristics were similar between the two groups. At index procedure, angiographic and procedural parameters were also similar except for CTO length which was longer in
P O S T E R A B S T R A C T S
The American Journal of Cardiology姞 APRIL 24 –27, 2012 ANGIOPLASTY SUMMIT ABSTRACTS/Poster
97S